Roivant Sciences Ltd.(NasdaqGM:ROIV) dropped from S&P Pharmaceuticals Select Industry Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.03 USD | +1.38% | +5.45% | -1.78% |
Apr. 05 | Arbutus Biopharma Obtains Favorable Court Order in Moderna Patent Lawsuit | MT |
Apr. 04 | Moderna Suffers Setback in Lawsuit by Arbutus | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.78% | 8.77B | |
+25.83% | 653B | |
+27.00% | 556B | |
-6.76% | 354B | |
+20.34% | 331B | |
+3.00% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-6.26% | 144B |
- Stock Market
- Equities
- ROIV Stock
- News Roivant Sciences Ltd.
- Roivant Sciences Ltd.(NasdaqGM: ROIV) dropped from S&P Pharmaceuticals Select Industry Index